Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Clinical Epidemiology of COPD: Insights From 10 Years of the COPDGene Study.

Maselli DJ, Bhatt SP, Anzueto A, Bowler RP, DeMeo DL, Diaz AA, Dransfield MT, Fawzy A, Foreman MG, Hanania NA, Hersh CP, Kim V, Kinney GL, Putcha N, Wan ES, Wells JM, Westney GE, Young KA, Silverman EK, Han MK, Make BJ.

Chest. 2019 May 30. pii: S0012-3692(19)31128-6. doi: 10.1016/j.chest.2019.04.135. [Epub ahead of print] Review.

PMID:
31154041
2.

Trends and Outcomes in Sepsis Hospitalizations With and Without Atrial Fibrillation: A Nationwide Inpatient Analysis.

Desai R, Hanna B, Singh S, Omar A, Deshmukh A, Kumar G, Foreman MG, Sachdeva R.

Crit Care Med. 2019 Aug;47(8):e630-e638. doi: 10.1097/CCM.0000000000003806.

PMID:
31094740
3.

Symptoms of anxiety and depression and use of anxiolytic-hypnotics and antidepressants in current and former smokers with and without COPD - A cross sectional analysis of the COPDGene cohort.

Iyer AS, Holm KE, Bhatt SP, Kim V, Kinney GL, Wamboldt FS, Jacobs MR, Regan EA, Armstrong HF, Lowe KE, Martinez CH, Dransfield MT, Foreman MG, Shinozaki G, Hanania NA, Wise RA, Make BJ, Hoth KF; COPDGene Investigators.

J Psychosom Res. 2019 Mar;118:18-26. doi: 10.1016/j.jpsychores.2019.01.002. Epub 2019 Jan 7.

PMID:
30782350
4.

Author Correction: Assembly of a pan-genome from deep sequencing of 910 humans of African descent.

Sherman RM, Forman J, Antonescu V, Puiu D, Daya M, Rafaels N, Boorgula MP, Chavan S, Vergara C, Ortega VE, Levin AM, Eng C, Yazdanbakhsh M, Wilson JG, Marrugo J, Lange LA, Williams LK, Watson H, Ware LB, Olopade CO, Olopade O, Oliveira RR, Ober C, Nicolae DL, Meyers DA, Mayorga A, Knight-Madden J, Hartert T, Hansel NN, Foreman MG, Ford JG, Faruque MU, Dunston GM, Caraballo L, Burchard EG, Bleecker ER, Araujo MI, Herrera-Paz EF, Campbell M, Foster C, Taub MA, Beaty TH, Ruczinski I, Mathias RA, Barnes KC, Salzberg SL.

Nat Genet. 2019 Feb;51(2):364. doi: 10.1038/s41588-018-0335-1.

PMID:
30647471
5.

Race and Gender Disparities are Evident in COPD Underdiagnoses Across all Severities of Measured Airflow Obstruction.

Mamary AJ, Stewart JI, Kinney GL, Hokanson JE, Shenoy K, Dransfield MT, Foreman MG, Vance GB, Criner GJ; COPDGene® Investigators.

Chronic Obstr Pulm Dis. 2018 Jul 2;5(3):177-184. doi: 10.15326/jcopdf.5.3.2017.0145.

6.

Assembly of a pan-genome from deep sequencing of 910 humans of African descent.

Sherman RM, Forman J, Antonescu V, Puiu D, Daya M, Rafaels N, Boorgula MP, Chavan S, Vergara C, Ortega VE, Levin AM, Eng C, Yazdanbakhsh M, Wilson JG, Marrugo J, Lange LA, Williams LK, Watson H, Ware LB, Olopade CO, Olopade O, Oliveira RR, Ober C, Nicolae DL, Meyers DA, Mayorga A, Knight-Madden J, Hartert T, Hansel NN, Foreman MG, Ford JG, Faruque MU, Dunston GM, Caraballo L, Burchard EG, Bleecker ER, Araujo MI, Herrera-Paz EF, Campbell M, Foster C, Taub MA, Beaty TH, Ruczinski I, Mathias RA, Barnes KC, Salzberg SL.

Nat Genet. 2019 Jan;51(1):30-35. doi: 10.1038/s41588-018-0273-y. Epub 2018 Nov 19. Erratum in: Nat Genet. 2019 Feb;51(2):364.

7.

Association of low income with pulmonary disease progression in smokers with and without chronic obstructive pulmonary disease.

Lowe KE, Make BJ, Crapo JD, Kinney GL, Hokanson JE, Kim V, Iyer AS, Bhatt SP, Hoth KF, Holm KE, Wise R, DeMeo D, Foreman MG, Stone TJ, Regan EA.

ERJ Open Res. 2018 Nov 12;4(4). pii: 00069-2018. doi: 10.1183/23120541.00069-2018. eCollection 2018 Oct.

8.

Common and Rare Variants Genetic Association Analysis of Cigarettes per Day Among Ever-Smokers in Chronic Obstructive Pulmonary Disease Cases and Controls.

Lutz SM, Frederiksen B, Begum F, McDonald MN, Cho MH, Hobbs BD, Parker MM, DeMeo DL, Hersh CP, Ehringer MA, Young K, Jiang L, Foreman MG, Kinney GL, Make BJ, Lomas DA, Bakke P, Gulsvik A, Crapo JD, Silverman EK, Beaty TH, Hokanson JE; ECLIPSE and COPDGene Investigators.

Nicotine Tob Res. 2019 May 21;21(6):714-722. doi: 10.1093/ntr/nty095.

9.

Potential Racial Disparities Using Current Lung Cancer Screening Guidelines.

Annangi S, Nutalapati S, Foreman MG, Pillai R, Flenaugh EL.

J Racial Ethn Health Disparities. 2019 Feb;6(1):22-26. doi: 10.1007/s40615-018-0492-z. Epub 2018 May 4.

PMID:
29729002
10.

Features of COPD as Predictors of Lung Cancer.

Carr LL, Jacobson S, Lynch DA, Foreman MG, Flenaugh EL, Hersh CP, Sciurba FC, Wilson DO, Sieren JC, Mulhall P, Kim V, Kinsey CM, Bowler RP.

Chest. 2018 Jun;153(6):1326-1335. doi: 10.1016/j.chest.2018.01.049. Epub 2018 Feb 13.

11.

Response.

Foreman MG, Flenaugh EL.

Chest. 2018 Feb;153(2):567. doi: 10.1016/j.chest.2017.05.021. No abstract available.

12.

Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years.

Bhatt SP, Kim YI, Harrington KF, Hokanson JE, Lutz SM, Cho MH, DeMeo DL, Wells JM, Make BJ, Rennard SI, Washko GR, Foreman MG, Tashkin DP, Wise RA, Dransfield MT, Bailey WC; COPDGene Investigators.

Thorax. 2018 May;73(5):414-421. doi: 10.1136/thoraxjnl-2017-210722. Epub 2018 Jan 11.

13.

Paratracheal Paraseptal Emphysema and Expiratory Central Airway Collapse in Smokers.

Copeland CR, Nath H, Terry NLJ, Wilson CG, Kim YI, Lynch DA, Bodduluri S, Wells JM, Dransfield MT, Díaz AA, Washko GR, Foreman MG, Bhatt SP; Genetic Epidemiology of COPD (COPDGene) Investigators.

Ann Am Thorac Soc. 2018 Apr;15(4):479-484. doi: 10.1513/AnnalsATS.201709-713OC.

14.

Examining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts.

Parulekar AD, Martinez C, Tsai CL, Locantore N, Atik M, Yohannes AM, Kao CC, Al-Azzawi H, Mohsin A, Wise RA, Foreman MG, Demeo DL, Regan EA, Make BJ, Boriek AM, Wiener LE, Hanania NA.

J Am Med Dir Assoc. 2017 Dec 1;18(12):1063-1068. doi: 10.1016/j.jamda.2017.09.028.

15.

The Use of Gabapentin for Pain and Agitation in Neonates and Infants in a Neonatal ICU.

Sacha GL, Foreman MG, Kyllonen K, Rodriguez RJ.

J Pediatr Pharmacol Ther. 2017 May-Jun;22(3):207-211. doi: 10.5863/1551-6776-22.3.207.

16.

The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic Findings.

Saccone NL, Baurley JW, Bergen AW, David SP, Elliott HR, Foreman MG, Kaprio J, Piasecki TM, Relton CL, Zawertailo L, Bierut LJ, Tyndale RF, Chen LS; Genetics and Treatment Networks of the Society for Research on Nicotine and Tobacco (SRNT).

Nicotine Tob Res. 2018 Mar 6;20(4):403-413. doi: 10.1093/ntr/ntx096.

17.

Impact of Comorbidities Among Medicaid Enrollees With Chronic Obstructive Pulmonary Disease, United States, 2009.

Westney G, Foreman MG, Xu J, Henriques King M, Flenaugh E, Rust G.

Prev Chronic Dis. 2017 Apr 13;14:E31. doi: 10.5888/pcd14.160333.

18.

Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups.

Foreman MG, Wilson C, DeMeo DL, Hersh CP, Beaty TH, Cho MH, Ziniti J, Curran-Everett D, Criner G, Hokanson JE, Brantly M, Rouhani FN, Sandhaus RA, Crapo JD, Silverman EK; Genetic Epidemiology of COPD (COPDGene) Investigators * .

Ann Am Thorac Soc. 2017 Aug;14(8):1280-1287. doi: 10.1513/AnnalsATS.201611-838OC.

19.

Rebuttal From Drs Foreman, Lopez, and Flenaugh.

Foreman MG, Lopez V, Flenaugh EL.

Chest. 2017 Feb;151(2):260-261. doi: 10.1016/j.chest.2016.09.044. Epub 2016 Oct 27. No abstract available.

PMID:
27983960
20.

COUNTERPOINT: Is It Time for Pulmonary Concierge Practices? Not Yet.

Foreman MG, Lopez V, Flenaugh EL.

Chest. 2017 Feb;151(2):257-259. doi: 10.1016/j.chest.2016.09.042. Epub 2016 Oct 27. No abstract available.

PMID:
27983959
21.

A continuum of admixture in the Western Hemisphere revealed by the African Diaspora genome.

Mathias RA, Taub MA, Gignoux CR, Fu W, Musharoff S, O'Connor TD, Vergara C, Torgerson DG, Pino-Yanes M, Shringarpure SS, Huang L, Rafaels N, Boorgula MP, Johnston HR, Ortega VE, Levin AM, Song W, Torres R, Padhukasahasram B, Eng C, Mejia-Mejia DA, Ferguson T, Qin ZS, Scott AF, Yazdanbakhsh M, Wilson JG, Marrugo J, Lange LA, Kumar R, Avila PC, Williams LK, Watson H, Ware LB, Olopade C, Olopade O, Oliveira R, Ober C, Nicolae DL, Meyers D, Mayorga A, Knight-Madden J, Hartert T, Hansel NN, Foreman MG, Ford JG, Faruque MU, Dunston GM, Caraballo L, Burchard EG, Bleecker E, Araujo MI, Herrera-Paz EF, Gietzen K, Grus WE, Bamshad M, Bustamante CD, Kenny EE, Hernandez RD, Beaty TH, Ruczinski I, Akey J; CAAPA, Barnes KC.

Nat Commun. 2016 Oct 11;7:12522. doi: 10.1038/ncomms12522.

22.

Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts.

Keene JD, Jacobson S, Kechris K, Kinney GL, Foreman MG, Doerschuk CM, Make BJ, Curtis JL, Rennard SI, Barr RG, Bleecker ER, Kanner RE, Kleerup EC, Hansel NN, Woodruff PG, Han MK, Paine R 3rd, Martinez FJ, Bowler RP, O'Neal WK; COPDGene and SPIROMICS Investigators ‡.

Am J Respir Crit Care Med. 2017 Feb 15;195(4):473-481. doi: 10.1164/rccm.201607-1330OC.

23.

Association Between Expiratory Central Airway Collapse and Respiratory Outcomes Among Smokers.

Bhatt SP, Terry NL, Nath H, Zach JA, Tschirren J, Bolding MS, Stinson DS, Wilson CG, Curran-Everett D, Lynch DA, Putcha N, Soler X, Wise RA, Washko GR, Hoffman EA, Foreman MG, Dransfield MT; Genetic Epidemiology of COPD (COPDGene) Investigators.

JAMA. 2016 Feb 2;315(5):498-505. doi: 10.1001/jama.2015.19431.

24.

Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease.

Checkley W, Foreman MG, Bhatt SP, Dransfield MT, Han M, Hanania NA, Hansel NN, Regan EA, Wise RA; COPDGene Study Investigators.

Respir Med. 2016 Feb;111:30-8. doi: 10.1016/j.rmed.2015.11.004. Epub 2015 Nov 11.

25.

Modelling Infectious Hematopoietic Necrosis Virus Dispersion from Marine Salmon Farms in the Discovery Islands, British Columbia, Canada.

Foreman MG, Guo M, Garver KA, Stucchi D, Chandler P, Wan D, Morrison J, Tuele D.

PLoS One. 2015 Jun 26;10(6):e0130951. doi: 10.1371/journal.pone.0130951. eCollection 2015.

26.

Reduced Bone Density and Vertebral Fractures in Smokers. Men and COPD Patients at Increased Risk.

Jaramillo JD, Wilson C, Stinson DS, Lynch DA, Bowler RP, Lutz S, Bon JM, Arnold B, McDonald ML, Washko GR, Wan ES, DeMeo DL, Foreman MG, Soler X, Lindsay SE, Lane NE, Genant HK, Silverman EK, Hokanson JE, Make BJ, Crapo JD, Regan EA; COPDGene Investigators.

Ann Am Thorac Soc. 2015 May;12(5):648-56. doi: 10.1513/AnnalsATS.201412-591OC. Erratum in: Ann Am Thorac Soc. 2015 Jul;12(7):1112. Stinson, Douglas J [corrected to Douglas S].

27.

Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans.

Putcha N, Han MK, Martinez CH, Foreman MG, Anzueto AR, Casaburi R, Cho MH, Hanania NA, Hersh CP, Kinney GL, Make BJ, Steiner RM, Lutz SM, Thomashow BM, Williams AA, Bhatt SP, Beaty TH, Bowler RP, Ramsdell JW, Curtis JL, Everett D, Hokanson JE, Lynch DA, Sutherland ER, Silverman EK, Crapo JD, Wise RA, Regan EA, Hansel NN; the COPDGene® Investigators.

Chronic Obstr Pulm Dis. 2014;1(1):105-114.

28.

Moving toward true inclusion of racial/ethnic minorities in federally funded studies. A key step for achieving respiratory health equality in the United States.

Burchard EG, Oh SS, Foreman MG, Celedón JC.

Am J Respir Crit Care Med. 2015 Mar 1;191(5):514-21. doi: 10.1164/rccm.201410-1944PP.

29.

Smoking-Associated Site-Specific Differential Methylation in Buccal Mucosa in the COPDGene Study.

Wan ES, Qiu W, Carey VJ, Morrow J, Bacherman H, Foreman MG, Hokanson JE, Bowler RP, Crapo JD, DeMeo DL.

Am J Respir Cell Mol Biol. 2015 Aug;53(2):246-54. doi: 10.1165/rcmb.2014-0103OC.

30.

Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus.

Hersh CP, Make BJ, Lynch DA, Barr RG, Bowler RP, Calverley PM, Castaldi PJ, Cho MH, Coxson HO, DeMeo DL, Foreman MG, Han MK, Harshfield BJ, Hokanson JE, Lutz S, Ramsdell JW, Regan EA, Rennard SI, Schroeder JD, Sciurba FC, Steiner RM, Tal-Singer R, van Beek E Jr, Silverman EK, Crapo JD; COPDGene and ECLIPSE Investigators.

BMC Pulm Med. 2014 Oct 24;14:164. doi: 10.1186/1471-2466-14-164.

31.

Menthol cigarette smoking in the COPDGene cohort: relationship with COPD, comorbidities and CT metrics.

Park SJ, Foreman MG, Demeo DL, Bhatt SP, Hansel NN, Wise RA, Soler X, Bowler RP.

Respirology. 2015 Jan;20(1):108-14. doi: 10.1111/resp.12421. Epub 2014 Oct 19.

32.

Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.

Criner GJ, Bourbeau J, Diekemper RL, Ouellette DR, Goodridge D, Hernandez P, Curren K, Balter MS, Bhutani M, Camp PG, Celli BR, Dechman G, Dransfield MT, Fiel SB, Foreman MG, Hanania NA, Ireland BK, Marchetti N, Marciniuk DD, Mularski RA, Ornelas J, Road JD, Stickland MK.

Chest. 2015 Apr;147(4):894-942. doi: 10.1378/chest.14-1676. Review.

33.

Executive summary: prevention of acute exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.

Criner GJ, Bourbeau J, Diekemper RL, Ouellette DR, Goodridge D, Hernandez P, Curren K, Balter MS, Bhutani M, Camp PG, Celli BR, Dechman G, Dransfield MT, Fiel SB, Foreman MG, Hanania NA, Ireland BK, Marchetti N, Marciniuk DD, Mularski RA, Ornelas J, Road JD, Stickland MK.

Chest. 2015 Apr;147(4):883-893. doi: 10.1378/chest.14-1677. Review. No abstract available.

34.

Pneumothorax risk factors in smokers with and without chronic obstructive pulmonary disease.

Hobbs BD, Foreman MG, Bowler R, Jacobson F, Make BJ, Castaldi PJ, San José Estépar R, Silverman EK, Hersh CP; COPDGene Investigators.

Ann Am Thorac Soc. 2014 Nov;11(9):1387-94. doi: 10.1513/AnnalsATS.201405-224OC.

35.

Ocean circulation model predicts high genetic structure observed in a long-lived pelagic developer.

Sunday JM, Popovic I, Palen WJ, Foreman MG, Hart MW.

Mol Ecol. 2014 Oct;23(20):5036-47. doi: 10.1111/mec.12924. Epub 2014 Oct 13.

PMID:
25231198
36.

Radiological correlates and clinical implications of the paradoxical lung function response to β₂ agonists: an observational study.

Bhatt SP, Wells JM, Kim V, Criner GJ, Hersh CP, Hardin M, Bailey WC, Nath H, Kim YI, Foreman MG, Stinson DS, Wilson CG, Rennard SI, Silverman EK, Make BJ, Dransfield MT; COPDGene Investigators.

Lancet Respir Med. 2014 Nov;2(11):911-918. doi: 10.1016/S2213-2600(14)70185-7. Epub 2014 Sep 9.

37.

Admixture mapping identifies a quantitative trait locus associated with FEV1/FVC in the COPDGene Study.

Parker MM, Foreman MG, Abel HJ, Mathias RA, Hetmanski JB, Crapo JD, Silverman EK, Beaty TH; COPDGene Investigators.

Genet Epidemiol. 2014 Nov;38(7):652-9. doi: 10.1002/gepi.21847. Epub 2014 Aug 11.

38.

FEV(1)/FEV(6) to diagnose airflow obstruction. Comparisons with computed tomography and morbidity indices.

Bhatt SP, Kim YI, Wells JM, Bailey WC, Ramsdell JW, Foreman MG, Jensen RL, Stinson DS, Wilson CG, Lynch DA, Make BJ, Dransfield MT.

Ann Am Thorac Soc. 2014 Mar;11(3):335-41. doi: 10.1513/AnnalsATS.201308-251OC.

39.

Modeling parasite dynamics on farmed salmon for precautionary conservation management of wild salmon.

Rogers LA, Peacock SJ, McKenzie P, DeDominicis S, Jones SR, Chandler P, Foreman MG, Revie CW, Krkošek M.

PLoS One. 2013;8(4):e60096. doi: 10.1371/journal.pone.0060096. Epub 2013 Apr 5.

40.

Racial differences in CT phenotypes in COPD.

Hansel NN, Washko GR, Foreman MG, Han MK, Hoffman EA, DeMeo DL, Barr RG, Van Beek EJ, Kazerooni EA, Wise RA, Brown RH, Black-Shinn J, Hokanson JE, Hanania NA, Make B, Silverman EK, Crapo JD, Dransfield MT; COPDGene Investigators.

COPD. 2013 Feb;10(1):20-7. doi: 10.3109/15412555.2012.727921.

41.

Sex and race factors in early-onset COPD.

Kamil F, Pinzon I, Foreman MG.

Curr Opin Pulm Med. 2013 Mar;19(2):140-4. doi: 10.1097/MCP.0b013e32835d903b. Review.

42.

Genes and chronic obstructive pulmonary disease.

Foreman MG, Campos M, Celedón JC.

Med Clin North Am. 2012 Jul;96(4):699-711. doi: 10.1016/j.mcna.2012.02.006. Epub 2012 Mar 6. Review.

43.

Genetic ancestry-smoking interactions and lung function in African Americans: a cohort study.

Aldrich MC, Kumar R, Colangelo LA, Williams LK, Sen S, Kritchevsky SB, Meibohm B, Galanter J, Hu D, Gignoux CR, Liu Y, Harris TB, Ziv E, Zmuda J, Garcia M, Leak TS, Foreman MG, Smith LJ, Fornage M, Liu K, Burchard EG; Health ABC and CARDIA Studies Groups.

PLoS One. 2012;7(6):e39541. doi: 10.1371/journal.pone.0039541. Epub 2012 Jun 21.

44.

Racial differences in quality of life in patients with COPD.

Han MK, Curran-Everett D, Dransfield MT, Criner GJ, Zhang L, Murphy JR, Hansel NN, DeMeo DL, Hanania NA, Regan EA, Make BJ, Martinez FJ, Westney GE, Foreman MG; COPDGene Investigators.

Chest. 2011 Nov;140(5):1169-1176. doi: 10.1378/chest.10-2869. Epub 2011 Jun 2.

45.

Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study.

Foreman MG, Zhang L, Murphy J, Hansel NN, Make B, Hokanson JE, Washko G, Regan EA, Crapo JD, Silverman EK, DeMeo DL; COPDGene Investigators.

Am J Respir Crit Care Med. 2011 Aug 15;184(4):414-20. doi: 10.1164/rccm.201011-1928OC.

46.

Clinical predictors of frequent exacerbations in subjects with severe chronic obstructive pulmonary disease (COPD).

Wan ES, DeMeo DL, Hersh CP, Shapiro SD, Rosiello RA, Sama SR, Fuhlbrigge AL, Foreman MG, Silverman EK.

Respir Med. 2011 Apr;105(4):588-94. doi: 10.1016/j.rmed.2010.11.015. Epub 2010 Dec 10.

47.

Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease.

Foreman MG, Kong X, DeMeo DL, Pillai SG, Hersh CP, Bakke P, Gulsvik A, Lomas DA, Litonjua AA, Shapiro SD, Tal-Singer R, Silverman EK.

Am J Respir Cell Mol Biol. 2011 Mar;44(3):316-22. doi: 10.1165/rcmb.2009-0360OC. Epub 2010 May 6.

48.

Associations of IL6 polymorphisms with lung function decline and COPD.

He JQ, Foreman MG, Shumansky K, Zhang X, Akhabir L, Sin DD, Man SF, DeMeo DL, Litonjua AA, Silverman EK, Connett JE, Anthonisen NR, Wise RA, Paré PD, Sandford AJ.

Thorax. 2009 Aug;64(8):698-704. doi: 10.1136/thx.2008.111278. Epub 2009 Apr 8.

49.

Polymorphic variation in surfactant protein B is associated with COPD exacerbations.

Foreman MG, DeMeo DL, Hersh CP, Carey VJ, Fan VS, Reilly JJ, Shapiro SD, Silverman EK.

Eur Respir J. 2008 Oct;32(4):938-44. doi: 10.1183/09031936.00040208. Epub 2008 Jun 11.

50.

Hospitalization for patients with sarcoidosis: 1979-2000.

Foreman MG, Mannino DM, Kamugisha L, Westney GE.

Sarcoidosis Vasc Diffuse Lung Dis. 2006 Jun;23(2):124-9.

PMID:
17937108

Supplemental Content

Loading ...
Support Center